Copyright Reports & Markets. All rights reserved.

Global Androstenedione Market Growth 2019-2024

Buy now

Table of Contents

    2019-2024 Global Androstenedione Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Androstenedione Consumption 2014-2024
        • 2.1.2 Androstenedione Consumption CAGR by Region
      • 2.2 Androstenedione Segment by Type
        • 2.2.1 4-AD
        • 2.2.2 ADD
      • 2.3 Androstenedione Consumption by Type
        • 2.3.1 Global Androstenedione Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Androstenedione Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Androstenedione Sale Price by Type (2014-2019)
      • 2.4 Androstenedione Segment by Application
        • 2.4.1 Arthritis Pharmaceuticals
        • 2.4.2 Fertility Control Pharmaceuticals
        • 2.4.3 Infectious Inflammation Pharmaceuticals
        • 2.4.4 Others
      • 2.5 Androstenedione Consumption by Application
        • 2.5.1 Global Androstenedione Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Androstenedione Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Androstenedione Sale Price by Application (2014-2019)

      3 Global Androstenedione by Players

      • 3.1 Global Androstenedione Sales Market Share by Players
        • 3.1.1 Global Androstenedione Sales by Players (2017-2019)
        • 3.1.2 Global Androstenedione Sales Market Share by Players (2017-2019)
      • 3.2 Global Androstenedione Revenue Market Share by Players
        • 3.2.1 Global Androstenedione Revenue by Players (2017-2019)
        • 3.2.2 Global Androstenedione Revenue Market Share by Players (2017-2019)
      • 3.3 Global Androstenedione Sale Price by Players
      • 3.4 Global Androstenedione Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Androstenedione Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Androstenedione Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Androstenedione by Regions

      • 4.1 Androstenedione by Regions
        • 4.1.1 Global Androstenedione Consumption by Regions
        • 4.1.2 Global Androstenedione Value by Regions
      • 4.2 Americas Androstenedione Consumption Growth
      • 4.3 APAC Androstenedione Consumption Growth
      • 4.4 Europe Androstenedione Consumption Growth
      • 4.5 Middle East & Africa Androstenedione Consumption Growth

      5 Americas

      • 5.1 Americas Androstenedione Consumption by Countries
        • 5.1.1 Americas Androstenedione Consumption by Countries (2014-2019)
        • 5.1.2 Americas Androstenedione Value by Countries (2014-2019)
      • 5.2 Americas Androstenedione Consumption by Type
      • 5.3 Americas Androstenedione Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Androstenedione Consumption by Countries
        • 6.1.1 APAC Androstenedione Consumption by Countries (2014-2019)
        • 6.1.2 APAC Androstenedione Value by Countries (2014-2019)
      • 6.2 APAC Androstenedione Consumption by Type
      • 6.3 APAC Androstenedione Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Androstenedione by Countries
        • 7.1.1 Europe Androstenedione Consumption by Countries (2014-2019)
        • 7.1.2 Europe Androstenedione Value by Countries (2014-2019)
      • 7.2 Europe Androstenedione Consumption by Type
      • 7.3 Europe Androstenedione Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Androstenedione by Countries
        • 8.1.1 Middle East & Africa Androstenedione Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Androstenedione Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Androstenedione Consumption by Type
      • 8.3 Middle East & Africa Androstenedione Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Androstenedione Distributors
      • 10.3 Androstenedione Customer

      11 Global Androstenedione Market Forecast

      • 11.1 Global Androstenedione Consumption Forecast (2019-2024)
      • 11.2 Global Androstenedione Forecast by Regions
        • 11.2.1 Global Androstenedione Forecast by Regions (2019-2024)
        • 11.2.2 Global Androstenedione Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Androstenedione Forecast by Type
      • 11.8 Global Androstenedione Forecast by Application

      12 Key Players Analysis

      • 12.1 BIOVET
        • 12.1.1 Company Details
        • 12.1.2 Androstenedione Product Offered
        • 12.1.3 BIOVET Androstenedione Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 BIOVET News
      • 12.2 Indo Phyto Chemicals
        • 12.2.1 Company Details
        • 12.2.2 Androstenedione Product Offered
        • 12.2.3 Indo Phyto Chemicals Androstenedione Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Indo Phyto Chemicals News
      • 12.3 Sito Bio
        • 12.3.1 Company Details
        • 12.3.2 Androstenedione Product Offered
        • 12.3.3 Sito Bio Androstenedione Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Sito Bio News
      • 12.4 Goto Pharmaceutical
        • 12.4.1 Company Details
        • 12.4.2 Androstenedione Product Offered
        • 12.4.3 Goto Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Goto Pharmaceutical News
      • 12.5 Tianjin King York
        • 12.5.1 Company Details
        • 12.5.2 Androstenedione Product Offered
        • 12.5.3 Tianjin King York Androstenedione Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Tianjin King York News
      • 12.6 Jiufu
        • 12.6.1 Company Details
        • 12.6.2 Androstenedione Product Offered
        • 12.6.3 Jiufu Androstenedione Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Jiufu News
      • 12.7 Yongning Pharma
        • 12.7.1 Company Details
        • 12.7.2 Androstenedione Product Offered
        • 12.7.3 Yongning Pharma Androstenedione Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Yongning Pharma News
      • 12.8 Jiangxi Hongyuan Pharmaceutical
        • 12.8.1 Company Details
        • 12.8.2 Androstenedione Product Offered
        • 12.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Jiangxi Hongyuan Pharmaceutical News
      • 12.9 Kaizon
        • 12.9.1 Company Details
        • 12.9.2 Androstenedione Product Offered
        • 12.9.3 Kaizon Androstenedione Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Kaizon News
      • 12.10 Xi’an Gaoyuan Bio-Chem
        • 12.10.1 Company Details
        • 12.10.2 Androstenedione Product Offered
        • 12.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Xi’an Gaoyuan Bio-Chem News
      • 12.11 Dongyao Pharmaceutical
      • 12.12 Huazhong Pharmaceutical
      • 12.13 Darui
      • 12.14 Danjiangkou Danao
      • 12.15 Dahua Pharmaceutical

      13 Research Findings and Conclusion

      Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
      Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
      Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.

      According to this study, over the next five years the Androstenedione market will register a 0.8% CAGR in terms of revenue, the global market size will reach US$ 200 million by 2024, from US$ 190 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Androstenedione business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Androstenedione market by product type, application, key manufacturers and key regions and countries.

      This study considers the Androstenedione value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      4-AD
      ADD
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Arthritis Pharmaceuticals
      Fertility Control Pharmaceuticals
      Infectious Inflammation Pharmaceuticals
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      BIOVET
      Indo Phyto Chemicals
      Sito Bio
      Goto Pharmaceutical
      Tianjin King York
      Jiufu
      Yongning Pharma
      Jiangxi Hongyuan Pharmaceutical
      Kaizon
      Xi’an Gaoyuan Bio-Chem
      Dongyao Pharmaceutical
      Huazhong Pharmaceutical
      Darui
      Danjiangkou Danao
      Dahua Pharmaceutical

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Androstenedione consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Androstenedione market by identifying its various subsegments.
      Focuses on the key global Androstenedione manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Androstenedione with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Androstenedione submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now